Chemours Files 8-K for Financial Statements and Exhibits

Ticker: CC · Form: 8-K · Filed: 2024-03-29T00:00:00.000Z

Sentiment: neutral

Topics: filing, financials

Related Tickers: CC

TL;DR

Chemours filed a routine 8-K for financial statements. No major news.

AI Summary

On March 28, 2024, The Chemours Company filed an 8-K to disclose information regarding its financial statements and exhibits. This filing is a routine update and does not appear to contain any material new financial information or significant corporate events.

Why It Matters

This filing serves as a standard disclosure for The Chemours Company, providing the SEC with updated financial statements and exhibits as required by regulations.

Risk Assessment

Risk Level: low — The filing is a standard procedural disclosure and does not indicate any new risks or material changes.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by The Chemours Company?

The primary purpose of this 8-K filing is to disclose information regarding its financial statements and exhibits, as indicated by the 'ITEM INFORMATION: Financial Statements and Exhibits' section.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is March 28, 2024, as stated under 'Date of Earliest Event Reported'.

In which state is The Chemours Company incorporated?

The Chemours Company is incorporated in Delaware, as indicated by 'State or Other Jurisdiction of Incorporation: Delaware'.

What is the principal executive office address for The Chemours Company?

The address of the principal executive offices for The Chemours Company is 1007 Market Street, Wilmington, Delaware 19801.

What is the SEC file number for The Chemours Company?

The SEC file number for The Chemours Company is 001-36794.

From the Filing

0001193125-24-081149.txt : 20240329 0001193125-24-081149.hdr.sgml : 20240329 20240328201800 ACCESSION NUMBER: 0001193125-24-081149 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240328 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240329 DATE AS OF CHANGE: 20240328 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Chemours Co CENTRAL INDEX KEY: 0001627223 STANDARD INDUSTRIAL CLASSIFICATION: CHEMICALS & ALLIED PRODUCTS [2800] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 464845564 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36794 FILM NUMBER: 24801603 BUSINESS ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 302 773 1000 MAIL ADDRESS: STREET 1: 1007 MARKET STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: Chemours Company, LLC DATE OF NAME CHANGE: 20141205 8-K 1 d814209d8k.htm 8-K 8-K Chemours Co false 0001627223 0001627223 2024-03-28 2024-03-28     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 March 28, 2024 Date of Report (Date of Earliest Event Reported)     The Chemours Company (Exact Name of Registrant as Specified in Its Charter)       Delaware   001-36794   46-4845564 (State or Other Jurisdiction of Incorporation)   (Commission File Number)   (I.R.S. Employer Identification No.) 1007 Market Street Wilmington , Delaware 19801 (Address of principal executive offices) Registrant’s telephone number, including area code: (302) 773-1000     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of Each Class   Trading Symbol(s)   Name of Exchange on Which Registered Common Stock ($0.01 par value)   CC   New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐       Item 7.01 Regulation FD Disclosure. On March 28, 2024, The Chemours Company (the “Company”) conducted a webcasted conference call on which management discussed the Company’s fourth quarter and full year 2023 financial results. A transcript of the call is furnished herewith as Exhibit 99.1. The information furnished with this report on Form 8-K, including Exhibit 99.1, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, and it will not be deemed incorporated by reference into any registration statement or other document filed under

View on Read The Filing